Botanical species · safety record

Prunus laurocerasus

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Prunus laurocerasus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Prunus laurocerasus L.

7Constituent measurements

1Safety records

7Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Prunus laurocerasus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Fresh leaves
Tail

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Prunasin	Leaves	Solvent extraction	—	Chromatographic tests	Resolve DOI
Prunasin	Leaves	Solvent extraction	6.45 Gram/100 gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
3,4-dihydroxybenzoic acid	Fruit unspecified	Solvent extraction	1.13 Percent	GC-MS	No resolvable identifier
Benzaldehyde	Leaves	Essential oil	99.7 Percent	GC-MS	No resolvable identifier
Cyanogenic glycosides	Leaves	Solvent extraction	—	—	No resolvable identifier
Hydrocyanic acid	Leaves	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
P-coumaric acid	Fruit unspecified	Solvent extraction	0.49 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Respiratory	Leaves	—	—	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Stanisavljevic, I. T., Lazic, M. L., Veljkovic, V. B., Stojicevic, S. S., Velickovic, D. T., Ristic, M. S. Kinetics of Hydrodistillation and Chemical Composition of Essential Oil from Cherry Laurel (Prunus laurocerasus L. var. serbica Pancic) Leaves . Journal of essential oil research, 2010, vol. 22, no. 6, p. 564-567.
Sendker, Jandirk., Ellendorff, Therese., Hoelzenbein, Aljoscha. Occurrence of Benzoic Acid Esters as Putative Catabolites of Prunasin in Senescent Leaves of Prunus laurocerasus . Journal of natural products, 2016, vol. 79, no. 7, p. 1724-1729. DOI
Ayaz, F. A., Kadioglu, A., Reunanen, M., Var, M. Phenolic acid and fatty acid composition in the fruits of Laurocerasus officinalis Roem. and its cultivars. Journal of food composition and analysis, 1997, vol. 10, no. 4, p. 350-357.
Waller, A. D. A New Method for the Quantitative Estimation of Hydrocyanic Acid in Vegetable and Animal Tissues. Proceedings of the royal society of london, series b: biological sciences, 1911, vol. 82, p. 574-87.
Herissey, H. On Prulaurasin, the Cyanogenetic Glucoside of the Leaves of Prunus laurocerasus. Archiv der pharmazie (weinheim, germany), 1908, vol. 245, p. 463-8.
Schmidt, B., Goerigk, D., Locher, L., J�ger, K., Bachmann, L., Coenen, M. Cyanide toxicosis in goats after ingestion of improperly stored green waste from cherry laurel (Prunus laurocerasus L.) - A case report Blaus�ureintoxikation von Ziegen nach Aufnahme von unsachgem�� gelagerten Gr�nabf�llen der Lorbeerkirsche (Prunus laurocerasus L.) - Ein Fallbericht . Praktische tierarzt, 2013, vol. 94, no. 8, p. 722-731.
Sendker, Jandirk., Nahrstedt, Adolf. Generation of primary amide glucosides from cyanogenic glucosides. Phytochemistry, 2009, vol. 70, no. 3, p. 388-393. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature